Adverse event profile by folate receptor status for vintafolide plus pegylated liposomal doxorubicin (PLD) vs PLD alone in platinum-resistant ovarian cancer [1]
Title: Adverse event profile by folate receptor status for vintafolide plus pegylated liposomal doxorubicin (PLD) vs PLD alone in platinum-resistant ovarian cancer
Author(s): Herzog, T.; Kutarska, E.; Bidzinski, M.; et al.
Source: European Journal of Cancer Volume: 49 Pages: S731 Published: 2013
Times Cited: 0
Nauka [2]